FOXP3 and neoplasm: In the present study, our results suggest that the presence of tumor-infiltrating mast cells and FOXP3 cells is associated with downmodulation of HLA-class I on tumor cells, lack of CD8+ T cells in these areas, and in effective tumor killing and eventual immune escape after anti-PD-1 therapy (Schema Fig. 6e).